Intec Pharma (NASDAQ:NTEC) and Rhythm Pharmaceuticals (NASDAQ:RYTM) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and profitability.
Volatility and Risk
Intec Pharma has a beta of 0.29, suggesting that its stock price is 71% less volatile than the SP 500. Comparatively, Rhythm Pharmaceuticals has a beta of 1.27, suggesting that its stock price is 27% more volatile than the SP 500.
This table compares Intec Pharma and Rhythm Pharmaceuticals’ net margins, return on equity and return on assets.
Earnings and Valuation
This table compares Intec Pharma and Rhythm Pharmaceuticals’ revenue, earnings per share and valuation.
Rhythm Pharmaceuticals is trading at a lower price-to-earnings ratio than Intec Pharma, indicating